Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 341 - 360 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »
Reset ↻

Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Read more ››

By: GlobeNewswire - 07 Oct 2024

Related companies: Beyond Air, Inc.

InspireMD Announces Approval of Investigational Device Exemption (IDE) Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent System

Read more ››

By: GlobeNewswire - 07 Oct 2024

Related companies: InspireMD, Inc.

RTI Surgical Announces Agreement to Acquire Collagen Solutions

Read more ››

By: GlobeNewswire - 07 Oct 2024

Related companies: RTI Surgical, Inc.

Cybrexa Therapeutics Announces First Patient Dosed with First-in-Class Peptide-Drug Conjugate CBX-12 in Phase 2 Trial in Ovarian Cancer

Read more ››

By: GlobeNewswire - 07 Oct 2024

Related companies: Cybrexa Therapeutics

Orchard Therapeutics and Er-Kim Announce Partnership to Broaden Access to Libmeldy to Eligible Patients in Turkey and Certain Eurasian Countries

Read more ››

By: GlobeNewswire - 07 Oct 2024

Related companies: Orchard Growth Partners Ltd. | Xinjiang Snow Mountain Orchard Food Co., Ltd. | Orchard Therapeutics plc | Orchard Therapeutics, USA

Intellia Therapeutics Announces Initiation of HAELO Phase 3 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)

Read more ››

By: GlobeNewswire - 07 Oct 2024

Related companies: Intellia Therapeutics, Inc.

ZyVersa Therapeutics Forms New Scientific Advisory Board to Support Development of Inflammasome ASC Inhibitor IC 100 for Obesity with Metabolic Complications

Read more ››

By: GlobeNewswire - 07 Oct 2024

Related companies: ZyVersa Therapeutics, Inc.

Dark Horse Consulting Launches Initiative for Certification of Manufacturing Capabilities

Read more ››

By: GlobeNewswire - 07 Oct 2024

Bionomics Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

Read more ››

By: GlobeNewswire - 07 Oct 2024

Insignis Therapeutics Announces Positive Results from Phase 1 Clinical Study of IN-001 Liquid Epinephrine Sublingual Spray for Anaphylaxis

Read more ››

By: GlobeNewswire - 07 Oct 2024

Related companies: Insignis Therapeutics, Inc

Nuvectis Pharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Read more ››

By: GlobeNewswire - 07 Oct 2024

Related companies: Nuvectis Pharma, Inc.

Sofwave Obtains U.S. Patent for Fat Tissue Reduction Technology

Read more ››

By: GlobeNewswire - 07 Oct 2024

Monopar Initiates Clinical Trial of Novel uPAR-Targeted Radiopharmaceutical Therapy in Advanced Cancers

Read more ››

By: GlobeNewswire - 07 Oct 2024

Related companies: Monopar Therapeutics Inc.

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Read more ››

By: GlobeNewswire - 07 Oct 2024

Related companies: Pacira BioSciences, Inc

Ultragenyx Receives Breakthrough Therapy Designation for Setrusumab (UX143) in Osteogenesis Imperfecta

Read more ››

By: GlobeNewswire - 07 Oct 2024

Related companies: Ultragenyx Pharmaceutical Inc.

Nusano Presenting at Industry Events in October

Read more ››

By: GlobeNewswire - 07 Oct 2024

Related companies: Nusano, Inc

Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium

Read more ››

By: GlobeNewswire - 07 Oct 2024

Related companies: Biora Therapeutics, Inc.

Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy

Read more ››

By: GlobeNewswire - 07 Oct 2024

Related companies: Akoya Biosciences, Inc.

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

Read more ››

By: GlobeNewswire - 07 Oct 2024

Related companies: OPKO Health, Inc.

Inspire Medical Systems, Inc. to Report Third Quarter 2024 Financial Results on November 4, 2024

Read more ››

By: GlobeNewswire - 07 Oct 2024

Related companies: Inspire Medical Systems, Inc. | Insplorion AB

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

to the top ↑